AEGR

Aegerion Pharmaceuticals, Inc. News Headlines

$28.02
*  
0.56
2.04%
Get AEGR Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading AEGR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AEGR Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Thursday 5/8 Insider Buying Report: AEGR
5/8/2014 2:49:32 PM - BNK Invest


Wider-than-Expected Loss at Aegerion - Analyst Blog
5/7/2014 2:50:01 PM - Zacks.com


Synageva Heading For Big Disappointment
4/22/2014 11:05:00 AM - Seeking Alpha


Synageva Heading For Big Disappointment
4/22/2014 10:00:00 AM - Seeking Alpha


Synageva Heading For Big Disappointment
4/22/2014 9:00:00 AM - SeekingAlpha


Aegerion Shares Up on Study Initiation - Analyst Blog
4/11/2014 3:30:01 PM - Zacks.com


Aegerion Pharmaceuticals Viability Threatened As Regulatory, Legal And Market Forces Close In
3/28/2014 11:00:00 AM - Seeking Alpha


Aegerion Pharmaceuticals' Viability Threatened As Regulatory, Legal And Market Forces Close In
3/28/2014 10:00:00 AM - SeekingAlpha


Trader bets on Aegerion rebound
3/12/2014 11:13:36 AM - optionMONSTER


Aegerion Pharmaceuticals (AEGR) Soars: Stock Rises 10.6% - Tale of the Tape
3/10/2014 8:39:01 AM - Zacks.com


Profit from Orphan Drugs: 3 Choices (Revised) - Analyst Blog
3/7/2014 2:33:01 PM - Zacks.com


Profit from Orphan Drugs: 3 Choices - Analyst Blog
3/5/2014 2:18:01 PM - Zacks.com


Shares Fall as Aegerion Posts Wider-than-Expected Loss - Analyst Blog
2/27/2014 1:26:01 PM - Zacks.com


Healthcare Stocks Posting Mid-Sized Gains; Aegerion Pharma Falls After Missing Q4 Revenue Expectations
2/26/2014 12:40:39 PM - MT Newswires


Sector Update: Healthcare
2/26/2014 12:39:42 PM - MT Newswires


Canadian Nod for Aegerion's Juxtapid - Analyst Blog
2/11/2014 4:45:01 PM - Zacks.com


Mexican Approval for Aegerion's Juxtapid - Analyst Blog
1/21/2014 4:20:01 PM - Zacks.com


Biotech Stock Roundup: Intercept Pharma Grabs the Limelight - Analyst Blog
1/15/2014 9:31:01 AM - Zacks.com


Is Aegerion Pharmaceuticals, Inc. (AEGR) Ready to Breakout? - Tale of the Tape
1/15/2014 9:22:01 AM - Zacks.com


Zacks #5 Rank Additions for Tuesday - Tale of the Tape
1/14/2014 9:30:01 AM - Zacks.com


Aegerion Gives Preliminary 2013 Update - Analyst Blog
1/10/2014 5:10:01 PM - Zacks.com


Isis Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days
12/23/2013 4:28:00 PM - Seeking Alpha


Aegerion Pharmaceuticals (AEGR) Catches Eye: Stock Up 5.5% - Tale of the Tape
11/22/2013 8:51:01 AM - Zacks.com


New Data on Aegerion's Juxtapid - Analyst Blog
11/19/2013 7:06:33 PM - Zacks.com


Isis Pharma Posts Lower Q3 Loss - Analyst Blog
11/6/2013 11:07:40 AM - Zacks.com